R25 DK067015/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2010	3
2011	4
2012	2
2013	2
2015	1
2016	2
2017	5
2018	3
2021	1
2022	1
2023	1
2024	0

1

Epithelial-Mesenchymal Transition and Breast Cancer.

Wu Y, Sarkissyan M, Vadgama JV. Wu Y, et al. J Clin Med. 2016 Jan 26;5(2):13. doi: 10.3390/jcm5020013. J Clin Med. 2016. PMID: 26821054 Free PMC article. Review.

2

Optimization Of Cancer Treatment Through Overcoming Drug Resistance.

Elshimali YI, Wu Y, Khaddour H, Wu Y, Gradinaru D, Sukhija H, Chung SS, Vadgama JV. Elshimali YI, et al. J Cancer Res Oncobiol. 2018;1(2):107. doi: 10.31021/jcro.20181107. Epub 2018 Feb 27. J Cancer Res Oncobiol. 2018. PMID: 29932172 Free PMC article.

3

CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-888 family/PDK1 axis.

He Q, Hao Q, Wu Y, Vadgama JV, Jiang Y. He Q, et al. Life Sci. 2023 Jan 1;312:121128. doi: 10.1016/j.lfs.2022.121128. Epub 2022 Nov 2. Life Sci. 2023. PMID: 36334805 Free PMC article.

4

SARS-CoV-2: characterisation and mitigation of risks associated with aerosol generating procedures in dental practices.

Ehtezazi T, Evans DG, Jenkinson ID, Evans PA, Vadgama VJ, Vadgama J, Jarad F, Grey N, Chilcott RP. Ehtezazi T, et al. Br Dent J. 2021 Jan 7:1-7. doi: 10.1038/s41415-020-2504-8. Online ahead of print. Br Dent J. 2021. PMID: 33414544 Free PMC article.

5

Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells.

Thant AA, Wu Y, Lee J, Mishra DK, Garcia H, Koeffler HP, Vadgama JV. Thant AA, et al. Anticancer Res. 2008 Nov-Dec;28(6A):3579-92. Anticancer Res. 2008. PMID: 19189638 Free PMC article.

6

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.

Austin D, Hamilton N, Elshimali Y, Pietras R, Wu Y, Vadgama J. Austin D, et al. Oncotarget. 2018 Sep 21;9(74):33912-33930. doi: 10.18632/oncotarget.26089. eCollection 2018 Sep 21. Oncotarget. 2018. PMID: 30338035 Free PMC article.

7

Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.

Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. Mishra DK, et al. Mol Cancer Ther. 2010 Jan;9(1):33-45. doi: 10.1158/1535-7163.MCT-09-0486. Epub 2010 Jan 6. Mol Cancer Ther. 2010. PMID: 20053773 Free PMC article.

8

Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer.

Wu Y, Elshimali Y, Sarkissyan M, Mohamed H, Clayton S, Vadgama JV. Wu Y, et al. Am J Cancer Res. 2012;2(1):104-15. Epub 2011 Nov 21. Am J Cancer Res. 2012. PMID: 22206049 Free PMC article.

9

FOXO1A is a target for HER2-overexpressing breast tumors.

Wu Y, Shang X, Sarkissyan M, Slamon D, Vadgama JV. Wu Y, et al. Cancer Res. 2010 Jul 1;70(13):5475-85. doi: 10.1158/0008-5472.CAN-10-0176. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551062 Free PMC article.

10

Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.

Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, Karlan B, Vadgama J, Lyons KM, Koeffler HP. Chien W, et al. Int J Oncol. 2011 Jun;38(6):1741-7. doi: 10.3892/ijo.2011.985. Epub 2011 Mar 23. Int J Oncol. 2011. PMID: 21455569 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year